SABCS

Postmenopausal Women Who Lose Weight May Have Reduced Breast Cancer Risk

December 9th 2017, 1:11am

Article

Losing even a moderate amount of extra weight significantly reduces the risk of breast cancer for postmenopausal women, a researcher reports.

Oropharyngeal Cancer Risks Include Number of Sexual Partners, Smoking

December 9th 2017, 12:52am

Article

The incidence of human papillomavirus-related oropharyngeal cancer (HPV-OPC) is on the rise. Researchers at Johns Hopkins University assessed survey data to determine whether the risk among the general population is rising as well. Results show that for most people, the risk remains low.

Talazoparib Beats Chemo in BRCA-Positive Breast Cancer

December 9th 2017, 12:30am

Article

Talazoparib, a PARP inhibitor is more effective than chemotherapy in reducing the risk of disease progression and death from BRCA-positive breast cancer.

Duration of Arimidex Treatment For Breast Cancer May Safely Be Shortened

December 8th 2017, 3:00am

Article

Researchers find that women with postmenopausal hormone receptor (HR)-positive breast cancer may undergo shorter treatments of Arimidex, which may in turn cause less bone fractures.

How Many Weeks of Adjuvant Herceptin Is Optimal for People with HER2-Positive Breast Cancer?

December 8th 2017, 1:50am

Article

A phase 3 clinical trial pitted a nine-week treatment of adjuvant Herceptin against the regimen of a full year of treatment for patients with HER2-positive breast cancer. Results show that the standard treatment of one year is still optimal.

Acupuncture Reduces AI-Associated Joint Pain in Women with Breast Cancer

December 7th 2017, 11:49pm

Article

To address compliance issues associated with treatment using aromatase inhibitors, researchers show that acupuncture effectively eases joint pain, a side effect from hormone therapy.

Controversial Breast Cancer Treatment Strategy May Protect Ovarian Function, Preserve Fertility

December 7th 2017, 10:36pm

Article

A reveiw of five clinical trial findings suggests that gonadotropin-releasing hormone analog has the potential to preserve ovarian function and fertility in premenopausal breast cancer patients.

Kisqali Extends Progression-Free Survival for Premenopausal Breast Cancer Subsets

December 7th 2017, 8:17pm

Article

New research demonstrates that a CDK4/6 inhibitor, used in combination with standard endocrine therapy with temporary ovarian suppression significantly improves progression-free survival in younger patients who currently have few treatment options.

Combination Regimen Shows Activity In HER2-Positive Breast Cancer

December 7th 2017, 3:30am

Article

The combination of Keytruda (pembrolizumab) and Herceptin (trastuzumab) showed promise for the treatment of women with Herceptin-resistant, PD-L1–positive, HER2-positive breast cancer.

Antibody-Drug Conjugate Improves Responses in Metastatic Triple-Negative Breast Cancer

December 7th 2017, 1:55am

Article

A stud presented at SABCS shows that IMMU-132, an antibody-drug conjugate, improves outcomes in women with heavily pretreated metastatic triple-negative breast cancer.